COMMUNIQUÉS West-GlobeNewswire

Kestra Medical Technologies, Ltd. to Report Second Quarter Fiscal 2026 Financial Results
03/12/2025
KIRKLAND, Wash., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced that it will report second quarter fiscal [...]
Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025
03/12/2025
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 3 DECEMBER 2025 at 09.00 EET Inside information: Orion to receive EUR 180 million milestone and updates full-year outlook for 2025 Orion Corporation has been [...]
Cession de 9 actifs immobiliers en Belgique
03/12/2025
Communiqué de presse Cession de 9 actifs immobiliers en Belgique Paris, le 3 décembre 2025 Clariane (CLARI.PA – ISIN FR0010386334) : Clariane annonce aujourd’hui la cession d’un portefeuille d’actifs de santé situés en [...]
Disposal of 9 real estate assets in Belgium
03/12/2025
Press release December 3 rd , 2025 Disposal of 9 real estate assets in Belgium Paris, December 3 rd , 2025 - Clariane (CLARI.PA - ISIN FR0010386334) today announces that it has completed the sale of a real estate [...]
Elevation Spine Center Expands Bend Clinic to Offer Easier Access to Advanced, Lasting Pain Relief
03/12/2025
Bend, OR, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Elevation Spine Center , one of the fastest-growing health clinics in Central Oregon, has completed a major expansion of its Bend facility. This expansion, finished on [...]
Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671
03/12/2025
Dosing of first MAD cohort in Phase 1 trial of O3R-5671 complete with no drug related adverse events Pharmacokinetic profile demonstrates long half-life and low intersubject variability Pharmacodynamic data from single [...]
Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer
03/12/2025
Internationally recognized radiopharmaceutical leader joins Actithera as the lead FAP-targeting asset advances to clinical development and the differentiated pipeline takes shape Brings over 15 years of global oncology [...]
Curium Establishes Legal Entity in China
03/12/2025
Curium has established a legal entity in China which represents a major milestone in Curium’s international growth strategy and will enhance Curium’s ability to serve patients with cancer across Asia Curium’s local [...]
Sapu Nano Unveils Broad-Applicability Deciparticle™ Nanomedicine Platform Capable of Formulating Multiple Hydrophobic Peptide, Macrolide, and Polyketide Drugs
03/12/2025
San Diego, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Sapu Nano , a clinical-stage nanomedicine company, today announced new data demonstrating that its proprietary Deciparticle ™ platform enables broad and consistent [...]
Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Primary Public Offering of Common Shares
03/12/2025
KIRKLAND, Wash., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced the pricing of its upsized underwritten [...]
Zymeworks Announces Participation in Upcoming Conferences
02/12/2025
• Late-breaking HERIZON-GEA-01 presentation at ASCO GI highlights the expanding clinical profile of Ziihera ® across HER2-driven gastrointestinal cancers by partner Jazz • Zymeworks to present a Trial-in-Progress poster [...]
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit
02/12/2025
SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the Oppenheimer Movers in Rare Disease Summit being held on December 11 [...]
Verano Awarded Conditional License to Commence Vertical Cannabis Operations in Texas
02/12/2025
Subject to final state approval, the Dispensing Organization License grants Verano permission to cultivate, process and dispense medical cannabis across the state to support expansion of the Texas Compassionate Use [...]
Publication relative à des notifications de transparence
02/12/2025
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 2 décembre 2025 , 22:30h CET / 16:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative [...]
Publication relating to transparency notifications
02/12/2025
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 2, 2025 , 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the [...]
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/12/2025
SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]
New Data Presented at the Clinical Trials on Alzheimer’s Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF
02/12/2025
TOKYO and CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: [...]
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/12/2025
MONTREAL and CHARLOTTE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a [...]
Clene to Provide CNM-Au8® ALS Program Update
02/12/2025
Webcast set for 8:30 a.m. ET on December 3rd SALT LAKE CITY, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a [...]

Pages